LifeStance Health Group, Inc. (LFST) stock
LFSTNasdaqServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30143% above fair value
$14.15−0.22 (-1.53%)
Close on Nov 12, 2026Market cap $5.41BP/E 74.5Yield –
LifeStance Health cash
Cash and short-term investments held at the end of each period.
LifeStance Health's cash was $218.82M at Sep 30, 2026. For fiscal 2025 it was $248.64M, up 60.9% from the year before. The highest annual figure on record is $248.64M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $248.64M | +60.9% |
| FY2024 | Dec 31, 2024 | $154.57M | +96.1% |
| FY2023 | Dec 31, 2023 | $78.82M | -27.4% |
| FY2022 | Dec 31, 2022 | $108.62M | -26.6% |
| FY2021 | Dec 31, 2021 | $148.03M | +686.2% |
| FY2020 | Dec 31, 2020 | $18.83M | +440.9% |
| FY2019 | Dec 31, 2019 | $3.48M | -69.3% |
| FY2018 | Dec 31, 2018 | $11.35M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $218.82M | +7.3% |
| Q2 FY2026 | Jun 30, 2026 | $225.94M | +19.6% |
| Q1 FY2026 | Mar 31, 2026 | $194.80M | +45.0% |
| Q4 FY2025 | Dec 31, 2025 | $248.64M | +60.9% |
| Q3 FY2025 | Sep 30, 2025 | $203.90M | +98.7% |
| Q2 FY2025 | Jun 30, 2025 | $188.93M | +117.2% |
| Q1 FY2025 | Mar 31, 2025 | $134.34M | +171.7% |
| Q4 FY2024 | Dec 31, 2024 | $154.57M | +96.1% |
| Q3 FY2024 | Sep 30, 2024 | $102.62M | +140.9% |
| Q2 FY2024 | Jun 30, 2024 | $86.97M | +9.3% |
| Q1 FY2024 | Mar 31, 2024 | $49.45M | -27.6% |
| Q4 FY2023 | Dec 31, 2023 | $78.82M | -27.4% |
| Q3 FY2023 | Sep 30, 2023 | $42.61M | -52.8% |
| Q2 FY2023 | Jun 30, 2023 | $79.61M | -17.7% |
| Q1 FY2023 | Mar 31, 2023 | $68.29M | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $108.62M | -26.6% |
| Q3 FY2022 | Sep 30, 2022 | $90.34M | -57.4% |
| Q2 FY2022 | Jun 30, 2022 | $96.69M | -65.0% |
| Q1 FY2022 | Mar 31, 2022 | $113.99M | +188.6% |
| Q4 FY2021 | Dec 31, 2021 | $148.03M | +686.2% |
| Q3 FY2021 | Sep 30, 2021 | $212.12M | +746.2% |
| Q2 FY2021 | Jun 30, 2021 | $276.19M | +1900.8% |
| Q1 FY2021 | Mar 31, 2021 | $39.49M | – |
| Q4 FY2020 | Dec 31, 2020 | $18.83M | +440.9% |
| Q3 FY2020 | Sep 30, 2020 | $25.07M | +121.0% |
| Q2 FY2020 | Jun 30, 2020 | $13.80M | – |
| Q1 FY2020 | Apr 13, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $3.48M | – |
| Q4 FY2018 | Dec 31, 2018 | $11.35M | – |
See a number that looks wrong?